PursueCare Completes Series B Fundraising Round and Acquires Digital Therapeutics Developed by Pear Therapeutics, Inc.

The Fundraising and Acquisition of Digital Therapeutics for SUD Strengthens PursueCare’s Ability to Provide Care for Individuals with Addiction PursueCare, a digital addiction treatment provider, today announced the completion of a Series B fundraising round totaling $20 million. The Series B round was led by T.Rx Capital and Yamaha Motor Ventures, with participation from Seyen Capital and OCA Ventures. The proceeds from the financing will support PursueCare’s ongoing collaborative care initiatives with health systems across 11 states, as well as expansion into value-based care with Medicaid managed care and other health plans. The company also announced the acquisition of the digital therapeutics reSET and reSET-O, originally developed and commercialized by Pear Therapeutics, Inc. The app-based digital therapeutics are the only FDA-authorized app-based treatments for SUD and OUD, respectively. They have been demonstrated to reduce substance use, increase retention in clinical care, and reduce overall healthcare expenditure. In recently presented data, reSET and reSET-O users saved Massachusetts $2,011 per user in healthcare resource-related costs. Additionally, the company acquired reSET-A, a digital therapeutic for alcohol use disorder that received FDA breakthrough device designation, supporting the company’s expansion into alcohol addiction treatment and prevention. Each product includes a 12-week course of therapy, in which patients are incentivized to complete le...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT Corey McCann Health IT Acquisitions Healthcare M&A Nicholas Mercadante OCA Ventures Pear Therapeutics PursueCare reSET reSET-O Seyen Capital T.Rx Capital Yamaha Motor Ventures Source Type: blogs